PTPN2 and adoptive T cell immunotherapy

Lead researcher

Dr Florian Wiede

Monash University, Department of Biochemistry and Molecular Biology

Years funded

This project will determine whether the immune response to tumours can be enhanced by targeting an inhibitory molecule known as PTPN2. The results will lead to a new and more effective approach for cancer treatment.

Funding Body

Cancer Council Research Grant


$100,000 pa for three years